Raymond V. Gilmartin served as the Chairman, President, and CEO of Merck & Co., Inc. from 1994 until May 2005. During his leadership, Gilmartin saw the company through significant changes and growth. By 2005, his total compensation was $2.4 million,...
Raymond V. Gilmartin served as the Chairman, President, and CEO of Merck & Co., Inc. from 1994 until May 2005. During his leadership, Gilmartin saw the company through significant changes and growth. By 2005, his total compensation was $2.4 million, including a salary of $1.6 million and a bonus of $800,000, tied directly to Merck’s performance. Notably, he received stock options to buy 250,000 shares at $31.84, aligning his interests with the company's success. Gilmartin was previously the CEO of Becton Dickinson, which adds to his extensive experience in management. After stepping down, he became a Special Advisor to Merck's Executive Committee, where he continued to provide his expertise until his retirement in 2006. His time at Merck was marked by key decisions, including the spin-off of Medco Health, which significantly boosted the value of his stock options.